Studied groups
|
A
|
Bd
|
Ce
|
Df
|
Total
|
---|
Variable
|
---|
No of subjects
|
98
|
295
|
139
|
103
|
635
|
Age Range yr (Date of birth)
|
20–33,1984–1998
|
15–19,1999–2003
|
11–14,2004–2007
|
7–10,2008–2011
|
7–33,1984–2011
|
Female/male ratio
|
59/39
|
139/156
|
75/64
|
49/54
|
322/313
|
Year and Time elapsed since the last dose of vaccination
|
2003 /15 yr
|
2004–7/ 13–15 yr
|
2004–7/ 10–13 yr
|
2008–11/ 7–10 yr
|
–
|
history of MV1 and MV2a
|
+
|
+
|
–
|
–
|
-
|
History of MRb
|
+
|
–
|
–
|
–
|
–
|
History of MMRc
|
No
|
One dose
|
2-doses
|
2-doses
|
–
|
- a: MV1, 2 measles vaccine first dose, second dose.
- b: MR: measles-rubella vaccine.
- c: MMR measles-mumps-rubella vaccine.
- d: GB: these subjects, in addition to receiving two doses of MV at the ages 9 and 15 months, were immunized with one dose of MMR vaccine at time of school entrance.
- e: This group was immunized with two–doses of MMR vaccine at the ages 12–15 months and 6 years.
- f: This group was immunized with two–doses of MMR vaccine at the ages of 12 and 18 months.